ストックスクリーナーアプリを入手
121.86
0.59%
0.71
アフターアワーズ：
122.24
0.38
+0.31%
Axsome Therapeutics Inc (AXSM) 最新ニュース
Smoking Cessation and Nicotine Addiction Pipeline Analysis 2025 by DelveInsight | Achieve LifeSciences, NFL Biosciences, Axsome Therapeutics - The Globe and Mail
Published on: 2025-08-27 15:00:18 - Newser
Is now a turning point for Axsome Therapeutics Inc.Bull Run & Low Drawdown Trading Strategies - Newser
MetLife Investment Management LLC Has $20.87 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Will breakout in Axsome Therapeutics Inc. lead to full recovery2025 Key Lessons & Growth Focused Entry Reports - Newser
26,307 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Axiom Investors LLC DE - MarketBeat
Major CNS Biotech Axsome Therapeutics Set for 6 High-Profile Healthcare Conferences in September 2025 - Stock Titan
Axsome Therapeutics to Participate in Investor Conferences in September - AInvest
Axsome Therapeutics to Participate in Upcoming Investor Conferences - MarketScreener
What data driven models say about Axsome Therapeutics Inc.’s futureTrade Signal Summary & Daily Profit Maximizing Tips - Newser
Real time breakdown of Axsome Therapeutics Inc. stock performance2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
Axsome Therapeutics, Inc. $AXSM Shares Sold by Hsbc Holdings PLC - MarketBeat
Order flow analysis tools used on Axsome Therapeutics Inc.Portfolio Growth Summary & AI Driven Stock Reports - Newser
Axsome Therapeutics Inc.’s volatility index tracking explainedTrade Analysis Summary & Weekly Top Performers Watchlists - Newser
Candriam S.C.A. Purchases New Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Sold by Aberdeen Group plc - MarketBeat
Predicting Axsome Therapeutics Inc. trend using moving averagesTrade Ideas & Verified Chart Pattern Trade Signals - Newser
Insider Transactions Reported | Axsome Therapeutics(AXSM)saw insider trading activity on 8/26/2025 - AInvest
Is Axsome Therapeutics Inc. trending in predictive chart modelsTrade Risk Summary & Technical Pattern Based Signals - Newser
Axsome Therapeutics Director Jeffs Roger sells 16694 shares at $120.08 on 2025-08-22. - AInvest
Atika Capital Management LLC Grows Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Will Axsome Therapeutics Inc. benefit from macro trendsGap Down & Stock Timing and Entry Methods - Newser
Is now a turning point for Axsome Therapeutics Inc2025 Technical Patterns & Weekly Return Optimization Plans - Newser
Axsome Therapeutics, Inc. $AXSM Shares Sold by Alethea Capital Management LLC - MarketBeat
Chart based analysis of Axsome Therapeutics Inc. trendsLong Setup & Accurate Technical Buy Alerts - Newser
Algert Global LLC Purchases Shares of 25,940 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Forecasting Axsome Therapeutics Inc. price range with options dataWeekly Investment Recap & Fast Exit and Entry Strategy Plans - Newser
What moving averages say about Axsome Therapeutics Inc.Risk Management & Real-Time Chart Breakout Alerts - Newser
Custom watchlist performance reports with Axsome Therapeutics Inc.Market Rally & Entry Point Confirmation Alerts - Newser
Best data tools to analyze Axsome Therapeutics Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - Newser
T. Rowe Price Investment Management Inc. Buys New Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
EntryPoint Capital LLC Purchases New Shares in Axsome Therapeutics, Inc. $AXSM - MarketBeat
92,640 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Jump Financial LLC - MarketBeat
Candlestick signals on Axsome Therapeutics Inc. stock todayIndex Update & Reliable Intraday Trade Plans - Newser
Axsome Therapeutics, Inc. $AXSM Shares Bought by Wellington Management Group LLP - MarketBeat
Risk vs reward if holding onto Axsome Therapeutics Inc.July 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Relative strength of Axsome Therapeutics Inc. in sector analysisPortfolio Return Report & Precise Trade Entry Recommendations - Newser
Sector ETF performance correlation with Axsome Therapeutics Inc.Price Action & Weekly Market Pulse Alerts - Newser
When is the best time to exit Axsome Therapeutics Inc.Trend Reversal & Accurate Intraday Trade Tips - Newser
1832 Asset Management L.P. Purchases Shares of 363,200 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Will Axsome Therapeutics Inc. bounce back from current supportWall Street Watch & Long-Term Capital Growth Ideas - Newser
How to recover losses in Axsome Therapeutics Inc. stockQuarterly Earnings Summary & Daily Technical Forecast Reports - Newser
Axsome Therapeutics: Strong Patent Protection and Market Expansion Amidst Generic Challenges - AInvest
Top Healthcare Stocks to Watch: Axsome Therapeutics, Rocket Pharmaceuticals, and Humana Receive Bullish Sentiments from Analysts - AInvest
Using Ichimoku Cloud for Axsome Therapeutics Inc. technicals2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Short Term Trend Reversal in Axsome Therapeutics Inc. PossibleJobs Report & Real-Time Chart Pattern Alerts - beatles.ru
Published on: 2025-08-22 16:55:26 - beatles.ru
Axsome stock rating reiterated by H.C. Wainwright amid generic challenge - Investing.com
Axsome Therapeutics, Inc. $AXSM Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Invesco Ltd. Raises Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Heatmap analysis for Axsome Therapeutics Inc. and competitors2025 Macro Impact & AI Forecasted Stock Moves - Newser
Axsome Therapeutics Receives Notice of Generic Version Filing from Apotex - AInvest
What makes Axsome Therapeutics Inc. stock price move sharplyWeekly Investment Report & Weekly Watchlist for Hot Stocks - Newser
Axsome Therapeutics Receives Paragraph IV Certification Notice - TipRanks
Axsome Therapeutics receives notice of proposed generic for Symbravo - Investing.com
Axsome stock rating reiterated at Outperform by RBC, citing FDA flexibility - Investing.com
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):